Anna M. Krzeczowska

Driven, doctorate-prepared nurse practitioner with over a decade of clinical nursing experience and board-certified in Adult-Gerontology Acute Care and Advanced Oncology. Dedicated to providing excellent, patient-centered care built upon evidence-based practice, research, innovation, and multidisciplinary collaboration. Special interests include the evolution of precision medicine in treating malignant hematologic disorders with a focus on acute myeloid leukemia.

Adult-Gerontology Acute Care Nurse Practitioner-Board Certified 2020146641 (Exp. 03/09/2026)

• Sub-investigator in a Phase 1b/2, Open-Label, Dose Finding, and Expansion Study of the BCL-2 Inhibitor BGB-11417 in Patients With Myeloid Malignancies. BGB-11417-103
• Sub-investigator in a Phase 1a/1b Dose-Escalation and Expansion Trial of TTI-622 in Patients with Advanced Hematologic Malignancies, Including Lymphoma, Leukemia, and Multiple Myeloma. TTI-622-01/C4971001

• Excellence in Advancing Nursing Practice Award 5/2024
• TGH Provider of the Month 4/2024
• Daisy Award Recipient 2021
• Oncology Nurse of the Year 2020
• Nurse's Week 2020 Medical Staff Scholarship Recipient
• Eighteen-times Daisy Award Nominee

• Member of the American Society of Hematology
• Member of the Florida Society of Clinical Oncology
• Member of the Advanced Practitioner Society for Hematology and Oncology
• Member of the European Society Association
• Member of the Society of Hematologic Oncology
• Member of the Oncology Nursing Society